Pharmaceutical Business review

FDA approves Rotem hemostasis delta analyzer

The delta analyzer facilitates surgeons by providing key information in just 5-10 minutes which enables surgical team to decide whether platelets, plasma, red blood cells or other blood components are in proper balance or need to be augmented by transfusion.

Rotem president Ken West said they can provide the delta analyzer to hospitals, blood banks and research centers thorough training and support from their headquarters in the Research Triangle Park area.